Post Profile

Prostate cancer hormone therapy tied to higher dementia risk

(Reuters Health) - Men who take hormone therapy for prostate cancer may have a higher risk of dementia than patients who receive different treatment for these malignancies, a U.S. study suggests.
read more


Related Posts

Radiotherapy Added To Hormone Treatment May Prevent Many Prostate Cancer Deaths

Health : Medical News Today

Results from a large study have shown that combining radiotherapy and hormone therapy in patients with prostate cancer significantly improved men's survival compared with hormone therapy treatment alone. The study was conducted by t...

Common Prostate Cancer Treatment Tied to Dementia

Health : Newswise Medical News

Androgen Deprivation Therapy, a common hormone therapy to treat prostate cancer, may double a man's risk of dementia, regardless of his age, Penn Medicine researchers reported.

Men at 'High' Skeletal Risk Prior to Prostate Cancer Hormone Therapy Likely to Have More Fractures After Treatment

Health : Newswise Medical News

In what is believed to be the first study to describe the impact on men with a 'high' risk of bone fracture who are receiving long-term androgen deprivation therapy (ADT) for prostate cancer, new research from The Cancer Institute o...

NIH-Funded Study Shows Increased Survival in Men with Metastatic Prostate Cancer Who Receive Chemotherapy When Starting Hormone Therapy

Health : Newswise Medical News

Men with hormone-sensitive metastatic prostate cancer who received the chemotherapy drug docetaxel given at the start of standard hormone therapy lived longer than patients who received hormone therapy alone, according to early resu...

Medical News Today: Hormone therapy for prostate cancer may raise dementia risk

Health : Medical News Today

Men treated with androgen deprivation therapy - a hormone therapy - for prostate cancer may be more than twice as likely to develop dementia, study finds.


Copyright © 2016 Regator, LLC